Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells

Atherosclerosis

Volumn 240, Issue 2, 2015, Pages 367-373

  Lee, Kang Pa ^a   Sudjarwo, Giftania W ^a   Jung, Seung Hyo ^a   Lee, Donghyen ^a   Lee, Dong Youb ^a   Lee, Gyoung Beom ^a   Baek, Suji ^a   Kim, Do Yoon ^b   Lee, Hwan Myung ^b   Kim, Bokyung ^a   Kwon, Seong Chun ^c   Won, Kyung Jong ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Hoseo University   (South Korea)

^c Kwandong University College of Medicine   (South Korea)

Author keywords

Carvacrol; Migration; Neointima; Proliferation; Reactive oxygen species; Vascular smooth muscle cells

Indexed keywords

CARVACROL; CYCLINE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PLATELET DERIVED GROWTH FACTOR BB; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; ANTIOXIDANT; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOREDUCTASE; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; TERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; AORTA; AORTA STRIP; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MALE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANGIOGENESIS; ANIMAL; CAROTID ARTERY INJURIES; CELL CULTURE; CELL MOTION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYDROGEN PEROXIDE; MALE; MONOTERPENES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; NEOINTIMA; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-SIS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84927131197     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.03.038     Document Type: Article

References (41)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
2. Lee C.K., Lee H.M., Kim H.J., Park H.J., Won K.J., Roh H.Y., et al. Syk contributes to PDGF-BB-mediated migration of rat aortic smooth muscle cells via MAPK pathways. Cardiovasc Res. 2007, 74:159-168.
3. Won K.J., Lee H.M., Lee C.K., Lin H.Y., Na H., Lim K.W., et al. Protein tyrosine phosphatase SHP-2 is positively involved in platelet-derived growth factor-signaling in vascular neointima formation via the reactive oxygen species-related pathway. J.Pharmacol. Sci. 2011, 115:164-175.
4. Newby A.C., Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J.Pathol. 2000, 190:300-309.
5. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:153-183.
6. Ronnstrand L., Heldin C.H. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int. J. Cancer 2001, 91:757-762.
7. Li C., Xu Q. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell. Signal 2000, 12:435-445.
8. Dubey R.K., Jackson E.K., Gillespie D.G., Zacharia L.C., Imthurn B., Keller P.J. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler. Thromb. Vasc. Biol. 2000, 20:964-972.
9. Lee H.M., Kim H.J., Park H.J., Won K.J., Kim J., Shin H.S., et al. Spleen tyrosine kinase participates in Src-mediated migration and proliferation by PDGF-BB in rat aortic smooth muscle cells. Arch. Pharm. Res. 2007, 30:761-769.
10. Clempus R.E., Griendling K.K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res. 2006, 71:216-225.
11. Chen K.C., Zhou Y., Xing K., Krysan K., Lou M.F. Platelet derived growth factor-induced reactive oxygen species in the lens epithelial cells: the redox signaling. Exp. Eye Res. 2004, 78:1057-1067.
12. Lee H.M., Jeon B.H., Won K.J., Lee C.K., Park T.K., Choi W.S., et al. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factor-beta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway. Circ. Res. 2009, 104:219-227.
13. Madamanchi N.R., Runge M.S. Redox signaling in cardiovascular health and disease. Free Radic. Biol. Med. 2013, 61C:473-501.
14. Abe J., Berk B.C. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med. 1998, 8:59-64.
15. Taniyama Y., Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003, 42:1075-1081.
16. Yoshizumi M., Abe J., Haendeler J., Huang Q., Berk B.C. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J.Biol. Chem. 2000, 75:11706-11712.
17. Won K.J., Jung S.H., Lee C.K., Na H.R., Lee K.P., Lee D.Y., et al. DJ-1/park7 protects against neointimal formation via the inhibition of vascular smooth muscle cell growth. Cardiovasc Res. 2013, 97:553-561.
18. Krimer N., Başer K.H.C., Tümen G. Carvacrol rich plants in Turkey. Chem. Nat. Comp. 1995, 31:37-42.
19. Aristatile B., Al-Numair K.S., Veeramani C., Pugalendi K.V. Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats. Fundam. Clin. Pharmacol. 2009, 23:757-765.
20. Oliveira Fde A., Andrade L.N., de Sousa E.B., de Sousa D.P. Anti-ulcer activity of essential oil constituents. Molecules 2014, 19:5717-5747.
21. Sokmen M., Serkedjieva J., Daferera D., Gulluce M., Polissiou M., Tepe B., et al. Invitro antioxidant, antimicrobial, and antiviral activities of the essential oil and various extracts from herbal parts and callus cultures of Origanum acutidens. J.Agric. Food Chem. 2004, 52:3309-3312.
22. Baser K.H. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr. Pharm. Des. 2008, 14:3106-3119.
23. Guimarães A.G., Xavier M.A., de Santana M.T., Camargo E.A., Santos C.A., Brito F.A., et al. Carvacrol attenuates mechanical hypernociception and inflammatory response. Naunyn Schmiedeb. Arch. Pharmacol. 2012, 385:253-263.
24. Yin Q.H., Yan F.X., Zu X.Y., Wu Y.H., Wu X.P., Liao M.C., et al. Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology 2012, 64:43-51.
25. Raines E.W. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 2004, 15:237-254.
26. Won K.J., Lee S.C., Lee C.K., Lee H.M., Lee S.H., Fang Z., et al. Cordycepin attenuates neointimal formation by inhibiting reactive oxygen species-mediated responses in vascular smooth muscle cells in rats. J.Pharmacol. Sci. 2009, 109:403-412.
27. Shimizu H., Nakagawa Y., Murakami C., Aoki N., Kim-Mitsuyama S., Miyazaki H. Protein tyrosine phosphatase PTPεM negatively regulates PDGFβ-receptor signaling induced by high glucose and PDGF in vascular smooth muscle cells. Am. J. Physiol. Cell. Physiol. 2010, 299. C1144-C1152.
28. Bornfeldt K.E., Raines E.W., Graves L.M., Skinner M.P., Krebs E.G., Ross R. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann. N. Y. Acad. Sci. 1995, 766:416-430.
29. Lee H.M., Lee C.K., Lee S.H., Roh H.Y., Bae Y.M., Lee K.Y., et al. p38 mitogen-activated protein kinase contributes to angiotensin II-stimulated migration of rat aortic smooth muscle cells. J.Pharmacol. Sci. 2007, 105:74-81.
30. Lacolley P., Regnault V., Nicoletti A., Li Z., Michel J.B. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res. 2012, 95:194-204.
31. Simons M., Edelman E.R., Rosenberg R.D. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J.Clin. Invest 1994, 93:2351-2356.
32. Bennett M.R., Schwartz S.M. Antisense therapy for angioplasty restenosis. Some critical considerations. Circulation 1995, 92:1981-1993.
33. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 2007, 39:44-84.
34. Kavoosi G., Teixeira da Silva J.A., Saharkhiz M.J. Inhibitory effects of Zataria multiflora essential oil and its main components on nitric oxide and hydrogen peroxide production in lipopolysaccharide-stimulated macrophages. J.Pharm. Pharmacol. 2012, 64:1491-1500.
35. Aeschbach R., Löliger J., Scott B.C., Murcia A., Butler J., Halliwell B., et al. Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem. Toxicol. 1994, 32:31-36.
36. Wilcox C.S. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol. Ther. 2010, 126:119-145.
37. Yamada J., Yoshimura S., Yamakawa H., Sawada M., Nakagawa M., Hara S., et al. Cell permeable ROS scavengers, tiron and tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation. Neurosci. Res. 2003, 45:1-8.
38. Mitchell J.B., Samuni A., Krishna M.C., DeGraff W.G., Ahn M.S., Samuni U., et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 1990, 29:2802-2807.
39. Kavoosi G., Teixeira da Silva J.A. Inhibitory effects of Zataria multiflora essential oil and its main components on nitric oxide and hydrogen peroxide production in glucose-stimulated human monocyte. Food Chem. Toxicol. 2012, 50:3079-3085.
40. Kappert K., Sparwel J., Sandin A., Seiler A., Siebolts U., Leppänen O., et al. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2644-2651.
41. Blanc A., Pandey N.R., Srivastava A.K. Synchronous activation of ERK1/2, p38MAPK and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease. Int. J. Mol. Med. 2003, 11:229-234.